Exciting Opportunity Brewing Up For Parkway Minerals NL- A Technical View!

Is Any Exciting Opportunity Brewing Up For Parkway Minerals NL- A Technical View!

Australian-headquartered fertiliser feedstock explorer company, Parkway Minerals NL (ASX: PWN) focusses on the development of large greensand deposits in Perth Basin. The company aims towards defining a significant resource base and discovering best means to retrieve potash, phosphate and other minerals from the Dandaragan Trough, which is counted among the world’s largest known glauconite deposits. The company possesses two fertiliser projects in Western Australia, including Lake Seabrook and Dandaragan Trough Project.

Besides, the company also holds stakes (31 percent) in Davenport Resources (ASX: DAV), successfully developing potash resources in Germany. Parkway also owns ~6.5mn shares in Lithium Australia (ASX: LIT).

Parkway’s stock price has jumped massively in the past two months by ~50 per cent, backed by some major developments by the company. Breaking two-months of stagnation in its stock price, the share price of the company marked a tremendous rise from the beginning of July 2019 from AUD 0.004 to AUD 0.006 (as on 23rd August 2019). The stock surpassed the Australian share market’s benchmark index S&P/ASX 200 that has delivered a negative return of ~1.87 per cent since 1st July 2019.

How is the Technical Needle moving on ASX: PWN?

PWN Daily chart (Source: Thomson Reuters)

On the daily chart, the share prices of the company have recently crossed the 4 year downward sloping trendline, and if the prices sustain above the breakout level, it could denote the entry of bulls.

However, the 14-day Relative Strength Index, a leading technical indicator, is showing a negative divergence with the share price actions. While the share prices of the company crossed its previous day high, the 14-day Relative Strength Index did not cross the previous high level, which corrected from the overbought zone.

Despite a negative divergence, the price actions are showing positive indications, and the 9-day EMA recently crossed the 21-day EMA from below, which denotes a positive signal.

Investors should now monitor the breakout range closely as a break above it could support the share prices of the company further;

PWN Monthly Chart (Source: Thomson Reuters)

On following the monthly chart, and post connecting the Fibonacci Series, we can observe that the share prices of the company are revolving around the 50.0 per cent projected level (A$0.007) and taking the support from the same level.

The downside projected level remains intact until the prices cross the high of the candle marked as 2, and investors should monitor the 50.0 per cent to 61.8 per cent projected level as these could act as the crucial support for the share prices of the company.

PWN last traded at AUD 0.006 on 23rd August 2019. The stock has generated a return of 20 per cent in the last six months.

Fundamental News Flow aiding the stock price movement

Parkway experienced the following remarkable developments in July and August 2019:

Acquisition of Consolidated Potash Corporation Ltd

The company announced a strategic acquisition of an unlisted Australian public company, Consolidated Potash Corporation Ltd (CPC) in August this year. Parkway informed that it has executed a Binding Terms Sheet to acquire 97.79 per cent of CPC and will move to compulsorily acquire the remaining 2.21 per cent. The acquisition of CPC provided Parkway with direct ownership interests in two highly prospective brine projects – Karinga Lakes Potash Project (KLPP) and New Mexico Lithium Project (NMLP, Central Lordsburg Playa) – in addition to its existing project portfolio of Lake Seabrook Potash Project (LSPP) and Dandaragan Trough Project (DTP).

The acquisition also provided the company with the opportunity to own the aMES™ technology, suitable for lithium and potash production as well as brine processing.

June 2019 Quarter Results

The company released its June 2019 quarterly report on 31st July 2019 on the ASX. The company notified about the major activities conducted during the quarter at its projects, which included:

  • Announcement of 5BT of Inferred Resource on Küllstedt exploration licence at Davenport Resources, in which Parkway owns 31 per cent stake. With this, the total Inferred Resource at South Harz totalled 4.9 BT @ 10.6 per cent K2O, including 1.6BT of silvinite @ 13.1 per cent.
  • Encouraging brine assays of more than 4,000mg/L potassium from sampling programme conducted at Lake Seabrook.
  • Strategic investment in Lithium Australia by owning 6.5 million shares.

Parkway reported a cash balance of AUD 140k for the quarter ending 30th June 2019.

Granting of Australian K-Max Patent

The company informed in July this year that it has received an Australian patent for K-Max process from IP Australia, marking a remarkable step in the marketing of the Dandaragan Trough and implementation of the technology to other deposits.

Given the strong upside momentum displayed by Parkway’s stock on ASX, investors are keenly eyeing further developments in line with company’s following business strategy:


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. The above article is sponsored but NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) under discussion. We are neither licensed nor qualified to provide investment advice through this platform.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report